Rahul Khurana MD

Retinal Disease, Uveitis

Partner and Vitreoretinal Surgeon at Northern California Retina Vitreous Associates and an Associate Clinical Professor in Ophthalmology at UCSF Medical Center.

Join to view full profile

2500 Grant RdMountain View, CA 94040
Phone+1 650-940-7000
Fax+1 650-988-7862

Dr. Khurana is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khurana's full profile Already have an account?

Summary

Rahul Khurana, MD, is a Retina Specialist and President/CEO at Northern California Retina Vitreous Associates, one of the largest retina practices in California. He is also a Clinical Associate Professor of Ophthalmology at the University of California, San Francisco. He currently serves as the Secretary of Online Education for the American Academy of Ophthalmology which includes Eyewiki, the ONE Network, and Clinical Webinars; and the Past President of the California Academy of Eye Physicians and Surgeons. He was the Editor-in-Chief of the AAO's Ophthalmic News and Education (ONE) Network.

After graduating from Stanford University with a BS and MS in Biology, Dr. Khurana earned his medical degree at Duke University. He completed his ophthalmology residency at the Doheny Eye Institute at the University of Southern California in Los Angeles, as well as a fellowship in Uveitis and Ocular Inflammation. This was followed by a Vitreoretinal fellowship at the Wilmer Eye Institute at Johns Hopkins Medical Center in Baltimore.

He has published more than 150 peer-reviewed scientific papers, presented over 200 abstracts and presentations, won numerous national awards and been involved in more than 100 clinical trials. He serves as a reviewer for Ophthalmology and Ophthalmology Retina. Dr. Khurana was recognized by the American Medical Association as one of the top 51 emerging national leaders expected to make a strong impact on the future of medicine.

Education & Training

Johns Hopkins UniversityFellowship, Surgical Retina and Vitreous, 2007 - 2009
University of Southern California/LAC+USC Medical CenterFellowship, Ocular Immunology/Uveitis, 2006 - 2007
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 2003 - 2006
Sutter Health/California Pacific Medical CenterInternship, Internal Medicine, 2002 - 2003
Duke University School of MedicineClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2004 - 2028
MD State Medical License 2007 - 2010
PA State Medical License 2001 - 2002
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification IntelleChart, MDIntelleSys, A Nextech Company, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification IntelleChart, MDIntelleSys, A Nextech Company, 2014, 2016-2017
Gold Medal Awardee RETICON, 2017

Clinical Trials

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery Start of enrollment: 2011 Jan 01
Completed
Phase 2
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions Start of enrollment: 2013 Jun 01
Completed
Phase 4
Intravitreal Gas for Vitreomacular Adhesion Start of enrollment: 2013 Nov 01
Withdrawn
Not Applicable

Publications & Presentations

PubMed

Cataract Progression and Risk Factors for Cataract Surgery after Pars Plana Vitrectomy in Phakic Eyes: An IRIS® Registry (Intelligent Research in Sight) Analysis.
Jay C Wang, Rahul N Khurana, Lynn Liu, Charles Li, Flora Lum
Ophthalmology. Retina. 2026-08-01
3 citations
Outcomes of Patients with Proliferative Diabetic Retinopathy Treated with Anti-VEGF Therapy and/or Panretinal Photocoagulation in the United States Who Were Lost to Fo...
Rahul N Khurana, Jay C Wang, Sen Zhang, Charles Li, Flora Lum
Ophthalmology. Retina. 2025-12-01
7 citations
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema.
Jennifer I Lim, Manuel J Amador, Dilsher S Dhoot, Avni Finn, Samantha Fraser-Bell
Ophthalmology. Retina. 2025-07-01

Journal Articles

Anterior Segment Migration of Dexamethasone Implant: Risk Factors, Complications, and Management
Rahimy E, Khurana RN, Curr Opin Ophthalmol, 1/1/2017
Reply
Wykoff CC, Le RT, Khurana RN, Wang R, Brown DM, Ou WC, Clark WL, Boyer DS, Am J Ophthalmol, 1/1/2017
SCORE2 Report 2: Study Design and Baseline Characteristics
Scott IU, VanVedhuisen PC, Ip MS, Biodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group, Ophthalmology, 1/1/2017

Books/Book Chapters

Review Questions in Ophthalmology
Chapter: Retina and Vitreous
Page 465.0 - 533.0Bansal AS, Chang LK, Khurana RNEditors: KC Chern and MA Saidel.Wolters Kluwer Health, Philadelphia, PAEdition 3rd,2015

Abstracts/Posters

Suprachoroidal Triamcinolone Acetonide in Combination With Intravitreal Aflibercept in Patients With Macular Edema Following Retinal Vein Occlusion: Results of the TAN...
Khurana R, RETICON 2017: The Retina Congress with Live Surgery, Chennai, India, 1/1/2017
Intravitreal Aflibercept for Previously Treated Macular Edema associated with Central Retinal Vein Occlusions: Two Year Results from the NEWTON Study
Khurana R, RETICON 2017: The Retina Congress with Live Surgery, Chennai, India, 1/1/2017
Dexamethasone Implant Anterior Chamber Migration: The Importance of the “Clinical Laboratory”
Khurana R, RETICON 2017: The Retina Congress with Live Surgery, Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, 2016; Chennai, India, , 1/1/2017

Lectures

Uveitis Controversies by the Bay
San Francisco, CA - 1/1/2016
Uveitis, San Diego!! (It’s Kind of a Big Deal)
San Diego, CA - 1/1/2014
Powerplay: Vitreoretinal Surgery in Inflamed Eyes
Toronto, ON - 1/1/2013

Other

Retinal Optical Coherence Tomography
Khurana RN, Bhisitkul RB, Foster BS, AAO Focal Points, Clinical Modules for Ophthalmologists
1/1/2014
Vogt-Koyanagi-Harada Disease
Khurana RN, Rao NA, Ophthalmology International
1/1/2006

Press Mentions

Combination Therapy for AMD Fails to Improve Vision Versus Single DrugAugust 2nd, 2025
Blind Spots: Comparing the Vision Costs of the Weight-Loss Drug BoomJune 18th, 2025
A Patient's Guide to Macular Degeneration: Symptoms and TreatmentFebruary 6th, 2025